What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose that Chicago Mercantile Exchange Holdings Inc. (CME) filed Amendment No. 2 to its Registration Statement on Form S-1, which is related to its upcoming Initial Public Offering (IPO) of Class A common stock.

What does filing an Amendment No. 2 to the S-1 Registration Statement signify for investors?

Filing an Amendment No. 2 indicates that CME is moving forward with its IPO process. It suggests that the company is providing updated or additional information to the SEC, potentially in response to comments or to reflect changes in its business, financials, or offering details since the initial filing. This is a standard procedural step in preparing for an IPO.

When did CME Group Holdings Inc. expect to complete its IPO based on this filing?

This filing itself does not provide a specific timeline or expected completion date for the IPO. It only indicates that Amendment No. 2 to the S-1 registration statement was filed on October 24, 2002, signifying progress in the registration process.

What is 'Regulation FD Disclosure' mentioned in the filing?

Regulation FD (Fair Disclosure) is an SEC rule that requires public companies to disclose material non-public information to all investors simultaneously. In this context, the filing itself, by disclosing the amendment to the S-1, is being made in compliance with Regulation FD.

CME 8-K SEC Disclosure — Oct 25, 2002

Summary

CME Group Inc. (CME) filed a Current Report (8-K) on October 24, 2002, primarily to disclose the filing of Amendment No. 2 to its Registration Statement on Form S-1 with the Securities and Exchange Commission. This amendment pertains to the company's initial public offering (IPO) of Class A common stock. For investors, this filing indicates that CME was actively progressing with its IPO plans at that time. The filing of Amendment No. 2 suggests that the company was providing updated or further details regarding its business, financials, or the terms of the offering in response to SEC review or to reflect changes since its initial S-1 filing. Investors interested in CME's upcoming IPO should view this as a positive step in the process, signaling continued momentum towards becoming a publicly traded entity.

Key Highlights

1CME Group Inc. filed an 8-K on October 24, 2002.
2The report primarily concerns the company's Initial Public Offering (IPO).
3CME filed Amendment No. 2 to its Registration Statement on Form S-1 (File No. 333-90106).
4This amendment relates to the planned offering of Class A common stock.
5The filing indicates ongoing progress with CME's transition to a public company.
6The document explicitly references Regulation FD Disclosure.
7Amendment No. 2 is provided as an exhibit to the 8-K filing.

CME GROUP INC. 8-K Report (Oct 25, 2002)

Summary

Key Highlights

Frequently Asked Questions